Pfizer

News

Truepill preps launch of virtual COVID-19 service for oral a...

Telehealth, diagnostics and pharmacy business Truepill will launch a new virtual care platform in the coming weeks that it says will provide "end-to-end" care for people with COVID-19.

News

Merck's oral COVID drug squeaks past FDA advisory committee

An FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Ridgeback's oral antiviral molnupiravir for mild-to-moderate COVID-19, saying it

News

GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer.

News

Pharma pledges rapid response to Omicron COVID variant

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to dev

News

The critical role of the generics sector during the pandemic

Could safety scupper Ionis, Pfizer's cholesterol drug vupano...

Ionis has reported phase 2b trial data for its Pfizer-partnered antisense drug vupanorsen for cholesterol lowering that showed it met its main efficacy targets, but raised a few safety conc

News